755
Participants
Start Date
July 15, 2020
Primary Completion Date
July 31, 2020
Study Completion Date
June 30, 2021
BBV152A - Phase I
0.5 ml of the vaccine will be administered intramuscularly twice at Day 0 and Day 14
BBV152B - Phase I
0.5 ml of the vaccine will be administered intramuscularly twice at Day 0 and Day 14
BBV152C - Phase I
0.5 ml of the vaccine will be administered intramuscularly twice at Day 0 and Day 14
Placebo - Phase I
0.5 ml of the Placebo will be administered intramuscularly twice at Day 0 and Day 14
BBV152A - Phase II
0.5 ml of the vaccine will be administered intramuscularly twice at Day 0 and Day 28
BBV152B - Phase II
0.5 ml of the vaccine will be administered intramuscularly twice at Day 0 and Day 28
All India Institute of Medical Sciences, Delhi
Pt BD SHARMA,PGIMS/UHS, Rohtak
Prakhar Hospital, Kanpur
Rana Hospital and Trauma Center, Gorakhpur
Redkar Hospital and Research Centre, Goa
Gillukar Multispeciality Hospital, Nagpur
Nizam's Institute of Medical Sciences, Hyderabad
King George Hospital, Visakhapatnam
Jeevan Rekha Hospital, Belagavi
SRM Hospital & Research center, Chennai
Institute of Medical Sciences and SUM Hospital, Bhubaneswar
All India Institute of Medical Sciences, Patna
Indian Council of Medical Research
OTHER_GOV
Bharat Biotech International Limited
INDUSTRY